Carlos Roberto Monti

Mutant p53 protein in serum could be used as a molecular marker in human breast cancer

Gabriela Balogh, Daniel Mailo, P. Roncoroni et al. · International Journal of Oncology · 2006 · 56 citations · Full text

Medicine, Molecular Biology, Oncology +17

T cells CD4+/CD8+ local immune modulation by prostate cancer hemi-cryoablation

Michael Cerqueira, Karen L. Ferrari, Amílcar Castro de Mattos et al. · World Journal of Urology · 2019 · 22 citations

Life Sciences, Immunology, Oncology +12

Burden of focal cryoablation versus brachytherapy versus active surveillance in the treatment of very low-risk prostate cancer: a preliminary head-to-head comprehensive assessment

Michael Cerqueira, Walker W. Laranja, ⁠Brunno Cezar Framil Sanches et al. · European Journal of Cancer Care · 2015 · 18 citations · Full text

Medicine, Oncology, Urology +17

Prognostic factors for late urinary toxicity grade 2-3 after conformal radiation therapy on patients with prostate cancer

Ricardo Akiyoshi Nakamura, Carlos Roberto Monti, Lísias Nogueira Castilho et al. · International braz j urol · 2007 · 18 citations · Full text

Medicine, Radiation Oncology, Urology +16

PSA-nadir at 1 year as a sound contemporary prognostic factor for low-dose-rate iodine-125 seeds brachytherapy

Leonardo Oliveira Reis, ⁠Brunno Cezar Framil Sanches, E.L. Zani et al. · World Journal of Urology · 2013 · 16 citations

Medicine, Oncology, Radiation Oncology +11